Presenter: Sherly Mosessian, Ph.D, SOFIE Chief Scientific Officer

Date: Wednesday, June 18, 2025
Time: 3:30pm – 4:30pm EDT

Dr. Mosessian earned her bachelors degree in Biochemistry, followed by her Ph.D from UCLA Department of Molecular, Medical Pharmacology, with publications in tumor signaling, molecular imaging targets and clinical trials of Position Emission Tomography (PET) probes. In her role as the Chief Scientific Officer of SOFIE she formulates the strategic plan for scientific objectives of the organization, including leading the FAPI clinical development program.

In this session, Dr. Mosessian will:

• describe the significance and potential of FAP as a target in oncology
• highlight recent developments in clinical trials with FAP targeting in therapy
• highlight recent developments in clinical trials with FAP targeting in imaging
• describe latest progress with FAPI academic global outreach program

Approved for 1.0 CEH credit from SNMMI.